VC-backed TScan Therapeutics raises $100m for IPO
TScan Therapeutics, a biopharmaceutical company, has raised about $100 million for its IPO after pricing its over 6.6 million shares at $15 per share.
TScan Therapeutics, a biopharmaceutical company, has raised about $100 million for its IPO after pricing its over 6.6 million shares at $15 per share.
Copyright PEI Media
Not for publication, email or dissemination